Navigation Links
Spring Weather Brings Flea Season
Date:4/3/2008

FDA Approves New Once-a-Month Flea Protection in a Convenient Chewable

Tablet

INDIANAPOLIS, April 3, 2008 /PRNewswire/ -- April showers bring May flowers. And springtime weather also brings the onslaught of insects and parasites, including fleas. For many dog owners, flea treatments are a necessary nuisance. But thanks to a new oral flea protection product from Eli Lilly and Company, protecting your dog from fleas or treating an infestation can be a pleasant experience.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080403/AQTH073)

Comfortis(R) (spinosad), recently introduced by Eli Lilly and Company, is the first FDA-approved, chewable, beef-flavored tablet that kills fleas and prevents flea infestations on dogs for a full month.

Comfortis(R) also offers safe and effective flea protection for pet owners who have children or have other pets in their household. With Comfortis(R), children can immediately touch the dog after treatment, and there is no transfer of the product to other pets by contact. Because it is administered orally, Comfortis(R) is also a great choice for dogs that swim or are bathed often, as well as dogs with flea allergy dermatitis, a common skin disease resulting from flea bites, and dogs receiving topical skin treatments.

Spinosad, the active ingredient in Comfortis(R), is environmentally friendly. The introduction of spinosad for use in agriculture led to a Presidential Green Chemistry Award in 1999 from the U.S. Environmental Protection Agency.

"Comfortis(R) provides an effective and convenient alternative that makes flea protection pleasant for owners and dogs alike," said Steve Connell, DVM, manager of technical, academic and consumer services for companion animal health at Lilly. "Comfortis(R) not only kills fleas quickly, it's also easy to give, mess-free and doesn't require the separation or isolation of pets after administration, as with some topically applied products."

Label comparisons indicate Comfortis(R) provides the fastest flea kill of any once-a-month product.(1) In fact, it kills adult fleas before they can lay eggs, thus preventing infestations.

Fleas can be a major problem for dogs and dog owners. Pets can be exposed to these blood-sucking parasites anywhere, and fleas can threaten a pet's health. In addition to annoying scratching and discomfort, fleas are a source of flea allergy dermatitis (FAD) and anemia and may be a source of tapeworm transmission.

For pet owners, treating fleas quickly is essential. A flea can begin biting your dog and feeding on its blood within seconds and can begin laying eggs within one to two days at a rate of 40 to 50 per day, causing an infestation in the home that can take months to eliminate. Because just a few fleas can multiply quickly, it is important to ensure your dog is continually protected to prevent future infestations.

"Veterinarians are always the best source of information for pet owners when it comes to flea protection," Connell said. "For pet owners with children and with other pets in the household or those who want to avoid the mess and inconvenience of topical treatments, Comfortis(R) is a great option to discuss with your veterinarian."

Comfortis(R) is available by prescription only and is offered in weight-specific doses for dogs of virtually any size. It should be given with food for maximum effectiveness and has been demonstrated safe for dogs and puppies 14 weeks of age and older.

Comfortis(R) is the second Lilly product approved by the FDA for the companion animal health market and is now available to U.S. veterinarians. For important safety information about Comfortis(R) and the product label, see the last page of this release or visit http://www.comfortis4dogs.com.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com. Information about Lilly products for pets is available at http://www.lillypet.com.

The most common adverse reaction recorded during clinical trials was vomiting. Other adverse reactions were decreased appetite, lethargy or decreased activity, diarrhea, cough, increased thirst, vocalization, increased appetite, redness of the skin, hyperactivity and excessive salivation. For product label, including important safety information, see back page.

(1) Advantage(R), Frontline(R), Revolution(R) label comparison.

Advantage(R) is a trademark of Bayer HealthCare, LLC. Frontline(R) is

a trademark of Merial. Revolution(R) is a trademark of Pfizer, Inc.


'/>"/>
SOURCE Lilly
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
2. Adult offspring of parents with PTSD have lower cortisol levels
3. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
4. Parents PTSD May Boost Stress in Offspring
5. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
6. International Consulting Firm Health Fitness Dynamics Hired to Oversee Springbrook Inns Planned New Spa
7. COLORBLENDS to Donate Portion of Sales of Spring Forward Daffodil Blend to the Christopher and Dana Reeve Foundation
8. Springer adds Advances in Therapy to journals portfolio
9. Lifespring Health Promotes Health and Fitness by Sponsoring Silicon Valley Marathon on November 3rd and 4th
10. Announcing Always Best Care Senior Services Expansion into Colorado Springs, Colorado
11. Cold Spring Harbor scientists devise novel, low-cost method of sifting genomes high-value regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Ga (PRWEB) , ... December 08, 2016 , ... ... as soon after surgery as possible. With this in mind, SIGVARIS has created ... (DVT or blood clot) during bed rest and provide the benefits of graduated ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance ... in Hamilton County, is embarking on a charity drive with the aim of ... homes for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts ...
(Date:12/8/2016)... AZ (PRWEB) , ... December 08, 2016 , ... ... firm with offices that serve communities in and around the greater Phoenix metropolitan ... the Homeless Youth Connection. , The mission of the Homeless Youth Connection is ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... The Compretta ... commercial and residential clients in and around the Hancock County area, is announcing the ... Hancock County Food Pantry. , The Hancock County Food Pantry has worked for more ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Pa. , Dec. 8, 2016  A new ... reports that the use of opioid therapy to treat ... increase the likelihood of more harmful consequences, including death. ... , M.D., and Zankhana Mehta , M.D., authored ... research on chronic opioid therapy. The study was published ...
(Date:12/8/2016)... , December 8, 2016 Information products and ... metrics in Scopus , the world,s largest abstract and ... to comprehensive metrics for journals from over 5,000 publishers. The new ... journals to subscribe to and when to adjust a journal,s editorial ... , , ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... their offering. ... The global chromatography market to grow at a ... Market 2016-2020, has been prepared based on an in-depth market analysis with ... growth prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology: